1. Introduction {#s0005}
===============

Criteria for prodromal Alzheimer's disease (AD) ([@bb0010], [@bb0095], [@bb0090], [@bb0100]) and AD dementia ([@bb0260]) diagnosis include structural imaging markers, such as MRI based hippocampus volumetry, molecular imaging markers, such as amyloid PET, and functional imaging markers, such as ^18^FDG-PET. All these imaging markers have already been evaluated in large multicenter cohorts, such as ADNI, EDSD, NEST-DD and others ([@bb0085], [@bb0200], [@bb0220], [@bb0310]).

Particularly, FDG-PET has proven a precise predictor of imminent conversion from mild cognitive impairment (MCI) to AD dementia ([@bb0205]). At the same time, PET imaging is relatively expensive and availability of PET scanners is limited. Resting state fMRI (rs-fMRI) has been discussed as a functional imaging alternative for ^18^FDG-PET ([@bb0350]). Decline of default mode network connectivity, a brain network encompassing key regions of AD pathology such as posterior cingulate, precuneus, inferior parietal lobes, prefrontal cortex and medial temporal lobes ([@bb0150]), has been shown in AD dementia and MCI patients compared to age matched controls in a range of studies ([@bb0065], [@bb0170], [@bb0355]). Results on diagnostic accuracies are mixed, ranging from 62% to \> 90% group separation of MCI or AD dementia cases from healthy control cases in monocenter studies ([@bb0115], [@bb0225]). Such variation across studies likely not only reflects differences in the cohorts, but also variation in acquisition parameters of rs-fMRI sequences between studies. High variability of group discrimination across sites, however, would severely diminish the value of rs-fMRI as an imaging biomarker of AD.

Multicenter studies in healthy people revealed high variability of task related functional MRI image properties, such as transient signals, smoothness and the shape of the hemodynamic response function, even when multicenter data stemmed from the same brand and model of scanners ([@bb0390]). Consistent with these findings, test-retest reliability studies of rs-fMRI suggest high intra-individual variability of resting state connectivity even in healthy people repeatedly scanned at the same scanner ([@bb0060], [@bb0215], [@bb0230], [@bb0265], [@bb0285], [@bb0315]), including long-term evaluation after more than 12 months ([@bb0050], [@bb0070], [@bb0180]). Multiscanner evaluation suggests high variability of signal-to-noise and contrast-to-noise ratios, particularly when using field strengths of 3T and higher ([@bb0215], [@bb0230], [@bb0240]). In an explicit linear model, center accounted for a large amount of variance across voxel-wise resting state connectivity ([@bb0330]).

Several rs-fMRI multicenter studies have investigated alterations of functional connectivity in AD and other neuropsychiatric conditions, but without consideration of multiscanner effects ([@bb0125]) even though protocols differed between sites in some studies ([@bb0065], [@bb0080], [@bb0250], [@bb0325], [@bb0355]). Some of these studies used the same scanner type across sites ([@bb0080], [@bb0125], [@bb0355]), but some did not ([@bb0065], [@bb0250], [@bb0325]).

Several studies reported techniques to reduce inter-scanner variability, mostly, however, in data from healthy people. One study probed a wide range of processing steps to reduce test-retest variability ([@bb0315]). Another study comparing different connectivity metrics found most stable results for cross-correlation as compared to cross-coherence and partial cross-correlation ([@bb0135]). Two studies in healthy adults and young people at risk of psychosis, respectively, used scanner as a covariate in a second-level linear ANOVA model ([@bb0020], [@bb0045]), another study in healthy adults used conjunction analysis across scanners ([@bb0235]). Only one previous study explicitly modelled center effects in healthy older people and MCI cases using a meta-analysis of between group effects across four different cohorts ([@bb0335]).

Here, we used rs-fMRI data of people with AD dementia, MCI and healthy older controls from the "German resting-state initiative for diagnostic biomarkers" ([www.psymri.org](http://www.psymri.org){#ir0010}) collected at five sites to compare previously employed measures of scan quality across sites ([@bb0210], [@bb0380]), determine the effect of multicenter acquisition on between group effects, and assess diagnostic accuracies from different univariate analysis approaches. We expected to find large heterogeneity of between group effects that would likely impair the use of multicenter rs-fMRI data as diagnostic biomarker for AD. We used the widely established structural measure of hippocampus volume that has been found to be stable against multicenter effects ([@bb0130]) as an internal benchmark for the functional connectivity metric.

2. Material and methods {#s0010}
=======================

The original data set consisted of 367 rs-fMRI scans that have been retrieved retrospectively from five sites within the framework of the "German resting-state initiative for diagnostic biomarkers" ([www.psymri.org](http://www.psymri.org){#ir0015}). After a first round of visual quality check, 350 rs-fMRI data were retained, whereas 17 scans were dropped due to severe problems with scan quality, incomplete scans or scans covering only parts of the brain. From the remaining 350 scans, all 100 scans from one site (site V) were rated as borderline quality due to severe susceptibility effects and subsequent analyses were conducted both with and without the scans from this site. Distribution of demographic characteristics of participants across sites is summarized in [Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}; the number of participants per scanner is shown in supplementary [table 1](#t0005){ref-type="table"}.Table 1Demographic characteristics, all sitesTable 1ADMCIControlsNo. cases (women)[1](#tf0005){ref-type="table-fn"}84 (46)115 (59)151 (82)Age (SD) \[years\][2](#tf0010){ref-type="table-fn"}72.0 (9.0)72.6 (8.0)69.0 (7.8)MMSE (SD), number[3](#tf0015){ref-type="table-fn"}22.4 (4.4), 8426.7 (1.8), 11528.9 (1.0) 115MoCA (SD), number[4](#tf0020){ref-type="table-fn"}--22.7 (3.0), 2226.4 (2.1), 19education (SD) \[years\][5](#tf0025){ref-type="table-fn"}10.9 (2.4)12.4 (3.3)12.9 (3.1)[^1][^2][^3][^4][^5][^6][^7]Table 2Demographic characteristics, one site excluded.Table 2ADMCIControlsNo. cases (women)[1](#tf0030){ref-type="table-fn"}53 (31)79 (43)118 (61)Age (SD) \[years\][2](#tf0035){ref-type="table-fn"}72.4 (8.8)74.8 (6.0)70.4 (6.2)MMSE (SD), number[3](#tf0040){ref-type="table-fn"}22.5 (4.4), 5326.5 (1.8), 7928.8 (1.0) 97MoCA (SD), number[4](#tf0045){ref-type="table-fn"}--22.7 (3.0), 2226.4 (2.1), 19education (SD) \[years\][5](#tf0050){ref-type="table-fn"}11.4 (2.1)13.0 (3.4)13.6 (3.1)[^8][^9][^10][^11][^12][^13][^14]

The retained data included scans from 84 patients with clinically probable AD according to NINCDS-ADRCA criteria ([@bb0255]), 115 individuals fulfilling Mayo criteria of amnestic MCI ([@bb0290]) and 151 healthy elderly control individuals. All participants were free of any significant neurological, psychiatric, or medical condition (except for AD or MCI in patients), in particular cerebrovascular apoplexy, vascular dementia, depression, or subclinical hypothyroidism, as well as substance abuse. Healthy controls were required to have no cognitive complaints and scored within one standard deviation of the age and education adjusted norm in all subtests of the Consortium to Establish a Registry of Alzheimer's Disease (CERAD) cognitive battery ([@bb0270]).

Written informed consent was provided by all subjects, or their representatives. The study was approved by local ethics committees at each of the participating centers, and has been conducted in accord with the Helsinki Declaration of 1975.

2.1. Imaging and data acquisition {#s0015}
---------------------------------

Data were obtained from five different 3.0 Tesla MRI scanners. Acquisition parameters for the rs-fMRI sequences are given in [Table 3](#t0015){ref-type="table"}. In one center (site I), the subjects were instructed to keep their eyes open, whereas in the remaining centers (sites II-V) all subjects were requested to close their eyes, relax, but not to fall asleep. Functional MRI was based on echo-planar imaging using scan durations between 6 and 9 min for the rs-fMRI sequence. The number of acquired time points was between 120 and 240 with a voxel size ranging from 2 × 2 × 2.6 up to 3.28 × 3.28 × 4.4 mm^3^ ([Table 3](#t0015){ref-type="table"}). Anatomical scans were obtained from all scanners with an isotropic resolution of 1 mm^3^ during the same session.Table 3Scanner characteristics.Table 3CenterModelManufacturerTR\
\[s\]TE\
\[s\]Flip angle \[°\]Matrix sizeField of view \[mm^3^\]Number of volumesVoxel size\
\[mm^3^\]Gap \[mm\]Slice thickness \[mm\]Spacing between slices \[mm\]Slice acquisition orderITrioTimSiemens2.610.0308064 × 64 × 42192 × 192 × 1512003 × 3 × 3.60.633.6Interleaved, ascendingIIVerioSiemens30.0309096 × 96 × 45192 × 192 × 1171202 × 2 × 2.60.622.6Contiguous, descendingIIIVerioSiemens2.580.0308064 × 64 × 47224 × 224 × 1651803.5 × 3.5 × 3.503.53.5Interleaved, ascendingIVTrioSiemens30.0308064 × 64 × 28210 × 210 × 1231203.28 × 3.28 × 4.40.444.4Interleaved, ascendingVAchievaPhilips20.0438296 × 96 × 32220 × 220 × 1282402.29 × 2.29 × 4044Interleaved, descending[^15]

2.2. MR processing {#s0020}
------------------

The **anatomical T**~**1**~**-weighted image** for each participant was segmented into gray matter, white matter, and cerebrospinal fluid (CSF) partitions of 1.5 mm isotropic voxel-size using the tissue prior free segmentation routine of the VBM8-toolbox ([@bb0165]) that extends Statistical Parametric Mapping (SPM8) ([@bb0160]). The Diffeomorphic Anatomical Registration Through Exponentiated Lie algebra (DARTEL) algorithm ([@bb0025]) was applied to normalize the T~1~-weighted gray matter and white matter partitions to the Montreal Neurological Institute (MNI) reference coordinate system using the default brain template included in VBM8. Individual flow-fields resulting from the DARTEL registration to the reference template were used to warp the gray matter segments. Voxel values of the warped gray matter segments were only modulated for the non-linear component of the deformation field, thus accounting at this step for differences in head size which are modeled by the affine component of the transformation.

**Functional MRI data** processing was carried out using Data Processing Assistant for Resting-State fMRI (DPARSF 3.2) ([@bb0055]), considering the recommendations from a recent systematic evaluation of processing alternatives ([@bb0315]). After the removal of the first six images to account for gradient field stabilization, the rs-fMRI data was slice time corrected and realigned to the temporal mean image. Slice time correction addresses the problem that, for functional MRI, the 3D image of one time point is typically obtained by acquiring a series of 2D slices, with each slice being acquired one after another within the full period of one repetition time, for instance three seconds ([Table 3](#t0015){ref-type="table"}). Thus, different slices of one 3D image measure the brain activity at a slightly different moment in time ([@bb0320]). Slice time correction compensates for phase shifts in the time series signal using the cardinal sine interpolation based on the fast Fourier transform ([@bb0320]). Sladky et al. found that this correction step improved the stability of estimates and magnitude of effects obtained from event-related and block design paradigms in task-based functional MRI ([@bb0320]). It is also commonly applied to rs-fMRI data for both approaches seed-based functional connectivity and independent component analysis ([@bb0115], [@bb0225], [@bb0265], [@bb0300], [@bb0385]), which assess the correlation or homogeneity of the time series signal of remote brain regions or voxels. Controversially, previous studies only found minor, non-significant effects of applying slice time correction to rs-fMRI data ([@bb0315], [@bb0375]). These observations may be due to the subsequent step of bandpass filtering, which eliminates high-frequency components of the data with a wavelength of less than ten seconds and, thus, reduces the influence of slight short-term inaccuracies. The anatomical T~1~-weighted image for each participant was coregistered to the mean functional image. The deformation fields generated by DARTEL from the anatomical T~1~-weighted images were used to project the functional scans from each subjects' native image space into the MNI reference space. We combined this step with the reslicing of all functional data to an isotropic resolution of 3 mm. The subsequent nuisance regression included covariates of head movement (rotation, translation, and derivatives) and the mean time courses for the global brain signal, the white matter segment signal, and the CSF segment signal. Although global signal regression was found to introduce negative correlations ([@bb0275], [@bb0315]), studies consistently reported that it effectively reduces the signal-to-noise ratio ([@bb0300], [@bb0315], [@bb0380]). Recently, Shirer et al. evaluated the influence of global signal regression on group separation but only found a minor, non-significant effect ([@bb0315]). Subsequently, the images were band-pass filtered using the frequency band 0.1--0.01 Hz and smoothed using a 6 mm full-width-at-half-maximum (FWHM) Gaussian kernel. Ventral posterior cingulate cortex (PCC) functional connectivity maps were calculated using a spherical seed with 4 mm radius, which was set at MNI position 0,-53,26 ([@bb0195]). Finally, Pearson correlation coefficients of the signal time courses were adjusted to be normally distributed using Fisher\'s Z-transform ([@bb0140]): z = 0.5 ln \[(1 + r)/(1 − r)\].

2.3. Extraction of hippocampus volumes {#s0025}
--------------------------------------

A mask for the hippocampus was obtained by manual delineation of the hippocampus in the reference template ([@bb0175]) using the interactive software package Display (McConnell Brain Imaging Centre at the Montreal Neurological Institute) and a previously described protocol for segmentation of the medial temporal lobe ([@bb0305]). Individual gray matter volumes of the hippocampus were extracted automatically from the warped gray matter segments by summing up the modulated gray matter voxel values within hippocampus ROI in the reference space.

3. Statistics {#s0030}
=============

3.1. Quality control measures for scanner effects {#s0035}
-------------------------------------------------

We compared previously employed scan characteristics across scanners and diagnostic groups, including:•Framewise displacement (FD) -- mean and percentage above threshold (0.5 mm) ([@bb0210], [@bb0295], [@bb0300], [@bb0380])•Temporal signal-to-noise ratio (tSNR) ([@bb0245], [@bb0370])•Standardized DVARS -- root mean square of change in signal intensity from one time point to the next ([@bb0295])•Percentage of outlier voxels ([@bb0400])•Foreground to background energy ratio (FBER) ([@bb0400])•Fractional amplitude of low frequency fluctuations (fALFF) ([@bb0385]).

Additionally, we compared the regional correlations between PCC and anterior medial prefrontal cortex (aMPFC) time courses between scanners and groups, based on spherical seed regions with a radius of 4 mm at MNI coordinates 0, − 53, 26 (PCC) ([@bb0195]) and − 6, 52, − 2 (aMPFC) ([@bb0015]).

To limit the number of measures, we decided not to use some previously employed measures ([@bb0400]), such as entropy focus criterion (EFC) ([@bb0030]), image smoothness (IS) ([@bb0400]), or ghost-to-signal ratio (GSR). The GSR needs manual interaction for the definition of the area of ghost artifacts in native subject space and was obsolete for the detection of poor scan quality as our scans underwent visual inspection. We excluded EFC and IS which target strong blurring, motion, and noise and become redundant when including tSNR, percentage of outlier voxels, FD, and FBER.

A description of the quality measures can be found in the supplementary material section.

3.2. Spatial pattern of group differences {#s0040}
-----------------------------------------

We determined differences in voxel-wise correlations of PCC activity between AD patients and controls and between MCI patients and controls using two different univariate approaches to take scanner effects into account:•First, we determined group differences using a fixed effects linear model with diagnosis and scanner as independent factors, henceforth referred to as *pooled analysis with scanner covariate*. Significant clusters were identified with at least 10 voxels passing the uncorrected threshold of p \< 0.01.•Secondly, we used a *second level analysis* with linear models of between group differences at the first level and a one-sample t-test of the between group effects across the 3 scanners for AD vs. control comparison and 5 scanners for the MCI vs. control comparison at the second level. Significant clusters were identified with at least 10 voxels passing the uncorrected threshold of p \< 0.01.

Additionally, we assessed the spatial coherence of voxel-wise group differences between single scanners using conjunction analysis ([@bb0155]). Conjunction analysis resembles an ANOVA model for detecting group effects for more than two groups, but allows setting a threshold k to define the minimum number of effects, so that a second level group effect is considered to be present in a given voxel if a significant group difference had been found for at least k individual scanners ([@bb0155]). With our data, the value of k could range from 1, indicating an effect for at least one single scanner, to 5, indicating that a group effect must be present for each of the five scanners.

3.3. Accuracy of group discrimination {#s0045}
-------------------------------------

We defined regions of interest (ROI) as those brain regions that showed significant group differences in the voxel-based comparisons of AD or MCI and healthy control subjects. Specifically, we binarized the statistical maps thresholded at p \< 0.01 as described above for each statistical approach (i.e., pooled analysis, and second level analysis) yielding 2 (statistical approach) × 2 (AD vs. controls and MCI vs. controls) = 4 different ROIs. For each of these ROIs, we extracted averaged Fisher\'s Z-transformed correlation coefficients. To this end, the individual voxel-wise correlation maps in MNI standard space were multiplied by the thresholded binary ROIs, and the voxel values within each ROI were averaged for each individual scan, yielding scalar markers as predictors in linear logistic regression analyses.

To obtain an estimate of the accuracy of group discrimination for each modality and analysis technique, we used block-wise cross validation with repeated random sampling, based on Gaussian-distributed random numbers generated in R. We repeatedly split the data set into 63.2% of training data and 36.8% of test data. For each of the repeatedly drawn training samples, the logistic regression parameters were estimated and subsequently applied to the remaining test data set. Classification accuracy, sensitivity, and specificity as well as area under the receiver operating characteristic curves were recorded for each test data set. The entire cross-validation process was iterated 1000 times to determine the variability of the estimates of accuracy across runs. We determined nonparametric bootstrap confidence intervals with the 2.5 and 97.5 percentiles defining the lower and upper limits of the confidence interval (([@bb0120]), Chapter 13). Logistic regression analysis was calculated in R, using function glm with the parameter \'family\' = binary.

To define a benchmark for the effect size of group discrimination, we repeated the bootstrapped determination of the area under the receiver operating characteristic curves for the widely established measure of hippocampus volume, averaged across left and right hemispheres.

3.4. Scanner effects {#s0050}
--------------------

We employed variance component analysis using libraries "nlme" and "ape" in R with the function "varcomp" to determine the effect of scanner on functional connectivity, with diagnosis as fixed effect covariate and scanner as random effect covariate. We determined the proportion of variance attributable to scanner relative to the variance attributable to error. Variances were scaled to sum to 1.

4. Results {#s0055}
==========

4.1. Quality control measures for scanner effects {#s0060}
-------------------------------------------------

Framewise displacement showed comparable displacements across sites, both in mean values as well as in percentage of framewise displacement \> 0.5 mm. Similarly, the foreground-to-background energy ratio, the fractional amplitude of low frequency fluctuations in PCC, and the mean functional connectivity between PCC and anterior medial prefrontal cortex indicated no outlying center (Supplementary Fig. 1 to 5). When looking at single sites, differences between diagnostic groups showed a general trend in the expected direction that only occasionally reached statistical significance. For instance, cognitively impaired patients showed slightly more head motion than controls (Supplementary Fig. 1) and lower temporal signal-to-noise ratio (supplementary figure 6). Mean whole brain temporal signal-to-noise ratio, the mean percentage of outlier voxels, and standardized DVARS identified an outlier in the site V data, with significantly decreased tSNR and standardized DVARS, and increased number of outlier voxels in the healthy control group compared to the MCI and AD group (Supplementary Figs. 6 to 8), one-sided Wilcoxon tests, p \< 0.01. Site II showed a significantly reduced tSNR compared to the other sites (Supplementary Fig. 6), two-sided t-test, p \< 0.001; but this systematic bias was evenly distributed across all subject groups.

4.2. Spatial pattern of group differences {#s0065}
-----------------------------------------

We found group differences between AD patients and controls and between MCI patients and controls both in the pooled data analysis as well as the second level analysis only at an uncorrected level of significance of p \< 0.01, but no effects at an uncorrected p-value of 0.001. Functional connectivity of the PCC was smaller in AD and MCI cases compared to controls when the data of site V were removed from the analysis. Peak areas of group effects were located in the mid temporal cortex, anterior cingulum and inferior parietal cortex (including angular gyrus) for the AD vs. control comparison, and in the precuneus, middle cingulate cortex, insula cortex, fusiform gyrus and medial temporal lobes (including amygdala and parahippocampal cortex) for the MCI vs. controls comparison ([Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}). The conjunction analysis revealed small clusters in only few regions when setting the minimum number of effects to k = 2, i.e. when group effects were significant in data from at least two scanners (data not shown). For the MCI vs. controls comparison, no cluster survived when the number of effects k was \> 2. When the data of site V were included in the analysis, effects were in the opposite direction with larger functional connectivity in the AD and MCI cases compared to controls (data not shown).Fig. 1AD vs. control comparisonGroup effects of PCC functional connectivity differences between AD patients and controls, using (Panel a) a fixed effect analysis pooling all scans across scanners with scanner as covariate, and (Panel b) a second level analysis with scanner as second level factor. Significant cluster of at least 10 voxel passing an uncorrected threshold of significance of p \< 0.01, are projected onto an anatomical MRI scan in MNI space. Numbers in the upper left corner of each image slice indicate the MNI z-coordinate, i.e. the axial section in MNI space.Color bars represent color coding for Cohen\'s d effect size estimates ([@bb0075]) for the pooled analysis, and T values for the second level analysis, respectively.Fig. 1Fig. 2MCI vs. control comparisonGroup effects of PCC functional connectivity differences between MCI patients and controls, using (Panel a) a fixed effect analysis pooling all scans across scanners with scanner as covariate, and (Panel b) a second level analysis with scanner as second level factor. Significant cluster of at least 10 voxel passing an uncorrected threshold of significance of p \< 0.01, are projected onto an anatomical MRI scan in MNI space. Numbers in the upper left corner of each image slice indicate the MNI z-coordinate, i.e. the axial section in MNI space.Color bars represent color coding for Cohen\'s d effect size estimates ([@bb0075]) for the pooled analysis, and T values for the second level analysis, respectively.Fig. 2

4.3. Accuracy of group discrimination {#s0070}
-------------------------------------

These analyses were only conducted in the sample without including the data of site V. The distribution of MCI and control cases was relatively well balanced across the four sites. Since the distribution of AD cases was imbalanced across sites, the analyses for the AD vs. control comparisons were repeated across all sites and across the only two sites with a balanced number of AD cases and controls.

For the AD vs. controls comparison, mean AUCs in the test data ranged from 74% for the second level data to 82% for the pooled data, and accuracies ranged from 69% for the second level data to 76% for the pooled data ([Table 4](#t0020){ref-type="table"} and [Figure 3](#f0015){ref-type="fig"}). For the MCI vs. controls comparison, AUCs (accuracies) ranged from 71% (66%) for the second level data to 81% (72%) for the pooled data ([Table 4](#t0020){ref-type="table"} and [Figure 4](#f0020){ref-type="fig"}).Fig. 3Areas under ROC and accuracy for AD vs. control comparisonsBox plots of AUC and accuracy levels from cross-validation logistic regression. Levels of AUC (Panel a) and accuracy (Panel b) were determined using bootstrapped logistic regression models on the discrimination between AD patients and controls following a pooled analysis with center covariate ("pooled"), and a second level analysis with center as second level factor ("2^nd^ level"), respectively. Analyses were repeated, using all AD and control data ("all") as well as only data from a subset of centers where number of AD cases and controls was matched between centers ("sub").Fig. 3Fig. 4Areas under ROC and accuracy for MCI vs. control comparisonsBox plots of AUC and accuracy levels from cross-validation logistic regression. Levels of AUC (Panel a) and accuracy (Panel b) were determined using bootstrapped logistic regression models on the discrimination between MCI patients and controls following a pooled analysis with center covariate ("pooled"), and a second level analysis with center as second level factor ("2^nd^ level"), respectively.Fig. 4Table 4Group discrimination in the test sampleTable 4AD vs. controlsAUC pooled allAUC pooled subAUC 2nd level allAUC 2nd level sub**Mean**0.8160.8220.7390.757**Lower CI**0.730.7210.630.635**Upper CI**0.8980.9180.8360.87Ac pooled allAc pooled subAc 2nd level allAc 2nd level sub**Mean**0.7610.7380.7080.688**Lower CI**0.6670.6340.6190.585**Upper CI**0.8410.8540.7940.805**MCI vs. controls**AUC pooled allAUC 2nd level all**Mean**0.8050.713**Lower CI**0.7190.617**Upper CI**0.8850.803Ac pooled allAc 2nd level all**Mean**0.720.662**Lower CI**0.6440.575**Upper CI**0.8080.74[^16][^17][^18]

For comparison, the AUCs for left and right averaged hippocampus volume were 86% \[2.5/97.5^th^ percentile confidence interval 77%/95%\] for the AD vs. controls comparison, and 74% \[2.5/97.5^th^ percentile confidence interval 65%/84%\] for the MCI vs. controls comparison.

To determine if levels of accuracy measures (AUC and overall accuracy) differed significantly between the values derived from the pooled vs. the 2^nd^ level data, we used the degree of overlap between confidence intervals of the bootstrapped cross-validation data following Afshartous\' rule ([@bb0005]). This rule considers the correlation of accuracy measures between samples and the ratio of the standard errors of the accuracy measures of both samples. Following this approach, neither AUCs nor overall accuracies were significantly different between the pooled and the 2^nd^ level test data for the AD vs. controls and the MCI vs. controls comparisons, respectively, at a two tailed significance level of p \< 0.05.

4.4. Scanner effects {#s0075}
--------------------

Excluding site V, for the AD vs. control comparison, the proportion of variance attributable to scanner relative to the error variance was 6.6% across all sites and 6.3% for the two sites with balanced group distribution, and was 5.1% for the MCI vs. control comparison.

5. Discussion {#s0080}
=============

In a relatively large multicenter data set of retrospectively pooled rs-fMRI data we found spatially restricted differences in PCC whole brain functional connectivity between AD patients and controls and MCI patients and controls, both in a pooled analysis and a second level analysis stratified according to scanner. The effects were in the expected direction with connectivity smaller in AD/MCI than in controls when removing the data of one site that had failed on visual data inspection, the quality assessments for tSNR and the standardized DVARS, but met all other quality assessments employed. Our findings lead to two major conclusions: Multicenter rs-fMRI using seed based functional connectivity has limited accuracy in the discrimination of AD and MCI cases from controls, and requires careful data quality checks beyond evaluation of global quality metrics, including visual inspection of all the data.

The regional distribution of diagnostic group effects in PCC connectivity found in the subset of data passing the visual quality check resembles the results in previous monocenter studies that reported reduced connectivity in MCI or AD within the posterior cingulate gyrus, inferior parietal lobes and medial temporal lobes ([@bb0035], [@bb0040], [@bb0065], [@bb0170], [@bb0225], [@bb0355]). Overall, the effect sizes of group differences were small, with regional effects passing only an uncorrected level of p \< 0.01. This finding suggests that multiscanner variability decreases between group effects in functional connectivity. This interpretation is supported by the contribution of 5.2% to 6.6% of the overall variability by scanner related variance in the variance component analysis. In addition, the poor overlap of between group effects across scanners in the conjunction analysis indicates major confounding of group differences by multiscanner variability.

Levels of diagnostic accuracy ranged between 69% based on second level analysis and 76% based on pooled analysis for the AD vs. control comparisons and 66% and 72% for the MCI vs. control comparisons, respectively, in our study. These values are at the lower range of those previously reported from monocenter studies that involved small samples and failed to employ a cross-validation analysis ([@bb0035], [@bb0225]).They are, however, close to previous estimates from the test data of cross-validated monocenter studies ([@bb0115]). It is important to note that the benchmark for assessing performance of a technique is the cross-validated accuracy in the test data, not the accuracy in the training data. According to this benchmark, our multicenter study is at the level of accuracy of monocenter studies. Thus, although the use of multicenter data increases the degrees of freedom of the test statistics it did not increase the power of group discrimination due to confounding inter-scanner variance. One has to consider, however, that the identification of the peak areas that were included in the accuracy estimation was not part of the cross-validation so that effects may be slightly overestimated.

The levels of accuracy for functional connectivity in our study were below the levels of accuracy for hippocampus volume, one of the best established imaging markers of AD to date (for review see ([@bb0345])), reaching 86% and 74% AUC for the AD vs. controls comparison, respectively. For the MCI vs. controls comparison, the mean AUC for pooled data functional connectivity (81%) was numerically higher than the AUC for hippocampus (74%). The confidence interval of the hippocampus AUC, however, was largely contained within the confidence interval of the functional connectivity measures, suggesting that the functional connectivity measures were not significantly more accurate for the MCI vs. controls discrimination than the easily accessible hippocampus volumetry.

The results were clearly sensitive to scan quality. When we included the large data set of site V that had severe susceptibility artifacts, the direction of the group differences was inverted. When we considered the global scan quality measures, the tSNR ([@bb0245]) and standardized DVARS ([@bb0295]) suggested that insufficient signal in the healthy control group was driving this effect. Interestingly, other metrics employed in other multiscanner data pooling activities, including the intrinsic functional connectivity for two key areas of the DMN ([@bb0400]), fractional ALFF ([@bb0385], [@bb0400]), foreground to background energy ratio ([@bb0400]), or subject head motion ([@bb0210], [@bb0295], [@bb0300], [@bb0380]), were inconspicuous for these data, suggesting that determining tSNR ([@bb0245]), standardized DVARS ([@bb0295]), and visual inspection of all the data are indispensable for multiscanner data pooling. This is relevant since large scale data pooling efforts such as the PCP Quality Assessment Protocol ([preprocessed-connectomes-project.org/quality-assessment-protocol/index.html](http://preprocessed-connectomes-project.org/quality-assessment-protocol/index.html){#ir0020}) and the 1000 functional connectomes project ([@bb0385], [@bb0400]) focus on the detection and correction of spatial displacements and head motion that were inconspicuous with the site V data.

Despite the high relevance of multiscanner variability of rs-fMRI data ([@bb0215], [@bb0230], [@bb0240]), the large majority of studies on multicenter rs-fMRI in neuropsychiatric diseases did not take multiscanner effects into account, even if protocols differed between sites ([@bb0065], [@bb0080], [@bb0125], [@bb0250], [@bb0325], [@bb0355]). Regional effects of group differences strongly overlapped between a fixed effect analysis, including scanner as covariate, and a second level analysis stratified according to scanner, but were more extended for the pooled analysis. Numerically, group discrimination was smaller based on the second level analysis compared to the pooled analysis, albeit this difference was not statistically significant. A second level analysis of voxel-wise functional connectivity using Fisher\'s z-transformed correlation coefficients resembles a center-wise voxel-based meta-analysis ([@bb0340]) that determines voxel-wise effect size within sites and then assesses the confidence level of the voxel-wise effect size estimates across sites. Such an approach has been used in one previous study across four cohorts of 129 MCI cases and 99 controls ([@bb0335]). The main outcome of this previous study were Cohen\'s d ([@bb0075]) effect size estimates that ranged between 0.10 to 0.48, representing moderate effect sizes of MCI vs. control differences in regions of interests that were empirically derived from proximity metrics without a priori region selection. These moderate effect sizes agree with the effect sizes of group differences below Cohen\'s d = 1 in our peak voxel analysis ([figures 1](#f0005){ref-type="fig"}a and [2](#f0010){ref-type="fig"}a).

An interesting question is the effect of multicenter acquisition on between subjects variability in trajectories of intra-individual change from longitudinal studies. Evidence here is still very limited. One recent study evaluated reproducibility of rs-fMRI connectivity across 13 different scanners at baseline and 7 to 60 days of follow-up in five healthy people per site ([@bb0215]), including different scanner types and vendors. In this study site differences in test-retest-variability of PCC connectivity were marginally not significant (p \< 0.06). This finding suggests that multicenter acquisition not only introduces higher variability of between group differences as shown in our current study, but may introduce additional noise into the assessment of trajectories of intra-individual change.

We need to consider several limitations of our study. First, the scan protocols were different between scanners. This is not the case in a prospectively planned cohort study with a unified protocol. Still, even in absence of a harmonized protocol previous studies have pooled rs-fMRI data in studying neuropsychiatric diseases so that these findings are pertinent to the present state of research. More homogeneous acquisition parameters may amend some of the scanner effects but at the same time limit the usefulness of multicenter acquisition in routine care, where differences in scanner type and manufacturer will not allow perfect alignment of scanning parameters across sites. We carefully checked the image quality of each single scan by visual inspection. As a result, we excluded the data of site V. The remaining data had high image quality upon visual inspection, consistent with the results of the quality metrics employed. Still, the combination of data from different scanning protocols and scanner resulted in high inter-scanner variability despite sufficient intra-scanner scan quality. In future, we plan to determine the effects of multiscanner acquisition from an ongoing prospective multicenter study in MCI, AD, and healthy controls that employs a harmonized rs-fMRI protocol across sites. Although we expect that the multicenter effects may be smaller in such a harmonized study, we still anticipate that multiscanner effects will limit accuracy of group discrimination. Secondly, different preprocessing protocols may be useful to reduce multiscanner variation. Here, we employed a preprocessing protocol that was oriented on the recommendations from a systematic evaluation of processing steps ([@bb0315]), and used cross-correlation as connectivity metric that has been found more stable than other connectivity metrics, such as cross-coherence and partial cross-correlation, in a previous study ([@bb0135]). We did, however, not systematically explore other processing steps and connectivity metrics. Thirdly, group discrimination accuracy can never perform better than the reference standard. The reference standard in our study for AD and MCI definition lacked CSF or PET biomarker evidence for most cases, but data came from expert centers experienced in the early diagnosis of AD and MCI. Still, a final judgment of the added value of rs-fMRI for AD diagnosis must await systematic evaluation of diagnostic accuracy in multicenter data from biomarker stratified cases.

In summary, we found spatially restricted group differences in resting state functional connectivity in AD patients and MCI patients compared to controls, limited by high multiscanner variability. The accuracy of group discrimination resembled findings from previous monocenter studies using a training/test data set approach, encouraging the conclusion that rs-fMRI at least when using seed based functional connectivity metrics may play a limited role in early diagnosis of AD or MCI. The discrimination accuracy in the test data did not reach the internal benchmark set by the established marker of hippocampus volumetry. This conclusion needs further corroboration in biomarker qualified multicenter cohorts. From a practical viewpoint, studies pooling multicenter rs-fMRI data should employ careful data quality checks that need to include tSNR, standardized DVARS, and visual inspection of all the data besides other established global metrics, and should use explicit modelling of scanner effects such as provided by second level models or center-based meta-analysis when focusing on univariate approaches. Potential usefulness of multivariate non-linear approaches such as provided by machine learning algorithms that were successfully employed in reducing multiscanner effects for structural connectivity data ([@bb0110], [@bb0105]) is another open area of research.
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[^1]: MMSE -- Mini Mental State Examination ([@bb0145])

[^2]: MoCA -- Montreal Cognitive Assessment ([@bb0280])

[^3]: Not significantly different between groups, χ^2^ = 0.315, 2 df, p = 0.85.

[^4]: Significantly different between groups, F(2, 347) = 7.5, p \< 0.001.

[^5]: Significantly different between groups, Kruskal Wallis Test, p \< 0.001.

[^6]: Significantly different between groups, Kruskal Wallis Test, p \< 0.001.

[^7]: Significantly different between groups, F(2, 323) = 11.4, p \< 0.001.

[^8]: MMSE -- Mini Mental State Examination ([@bb0145])

[^9]: MoCA -- Montreal Cognitive Assessment ([@bb0280])

[^10]: Not significantly different between groups, χ[2](#tf0035){ref-type="table-fn"} = 0. 689, 2 df, p = 0.71.

[^11]: Significantly different between groups, F(2, 247) = 9.8, p \< 0.001.

[^12]: Significantly different between groups, Kruskal Wallis Test, p \< 0.001.

[^13]: Significantly different between groups, Kruskal Wallis Test, p \< 0.001.

[^14]: Significantly different between groups, F(2, 246) = 9.73, p \< 0.001.

[^15]: All centers used an echo-planar imaging (EPI) sequence with axial slice orientation.

[^16]: Ac -- Accuracy.

[^17]: AUC -- Area under the ROC curve.

[^18]: sub - subsample from two scanners with matched numbers of AD patients and controls.
